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Abstract. A stochastic model is introduced to describe the growth of cancer affected by anti-
cancer therapeutics of Chondroitin Sulfate (CS). The parameters values of the stochastic model
are estimated via maximum likelihood function. The numerical method of Euler-Maruyama will
be employed to solve the model numerically. The efficiency of the stochastic model is measured
by comparing the simulated result with the experimental data.
1. Introduction
World Health Organization (WHO) reported that breast cancer is the most common women’s
malignancy with the majority of deaths occuring in the most part of the world [1]. In Malaysia,
breast cancer was accounted for 32.1% of all cancers among women in 2007 [2, 3].
There are varieties of molecules with various pathway that contribute to the apoptosis
mechanism in cancer cell. But, the final marker in apoptosis mechanism is caspase-3 [4]. Thus,
the activation of caspase-3 pathway can be positioned as activitors of the death cascade of
apoptosis [6]. Apoptosis plays an important roles in the cancer treatment and it is the most
important mechanism for cancer therapy. Hence, a better understanding of apoptosis process
opens a new class of targeted therapeutics in cancer treatment.
Generally, some of the treatment methods are surgery, chemotherpy, radiation therapy
and targeted therapy. Targeted therapy is a much sharper method and has proven to be
highly successful in cancer treatment, with fewer side effects [5, 7]. Nowadays, reseachers are
investigating for potent, safe and effective anticancer drugs to overcome resistance and reduce
side effects. Currently, the role of Chondroitin Sulfate (CS) as a potent in anticancer activities
and also as anticancer are among the reserachers interest [8].
During years, some researchers have worked on mathematical modelling of the effect of
targeted therapy on cancer treatment. However, to the best of our knowledge, no theoretical
studies on proposing a stochastic model of targeted cancer therapies. In biological pocesses of
cancer treatment, there are existing in nature that the cancer cell under treatment are exposing
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to random influences due to the interplay of therapy and resistance [9]. This findings lead to
the development of a mathematical model that subject to the random effects.
2. Mathematical Model
This section devotes to the development of stochastic model of the apoptotic mechanism induced
by CS. It starts with the understanding of apoptosis pathway as shown in Figure 1.
Figure 1. Apoptosis Pathway Induced by CS [10]
In Figure 1, CS binds to the cancer cells at a rate k1. Subsequently the CS-cancer cells bound
will induced the activation of Caspase-3. The activated Caspase-3 will promotes cell death or
specifically known as apoptosis mechanism at a rate k2. The mechanism of this pathway can be
transformed into chemical reactions as
λ+X
k1−−−−→
induce
Y
k2−−−−→
induce
Apoptosis (1)
Reaction (1) can be transformed into ordinary differential equation (ODEs) as follows
dX = −k1λXdt (2)
dY = (k1λX − k2Y )dt (3)
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ODEs (2) and (3) are transformed into SDEs by perturbing the parameters k1 and k2 in Equation
(2) and (3), respectively such that
k1 → k1 + σdW
dt
(4)
k2 → k2 + σdW
dt
. (5)
These yields
dX = −k1λXdt+ σ1XdW (t) (6)
dY = (k1λX − k2Y )dt+ σ2Y dW (t) (7)
where X is the cancer cell, Y is the activation of caspase-3. Here, σ > 0 is the diffusion coefficient
and the process dW for t ≥ 0 is a Gaussion white noise process with mean zero and variance,
∆t.
3. Numerical Method and Parameter Estimation
The numerical solution of stochastic models are simulated via a Euler-Maruyama method with
0.5 order of convergence. This method can be represented by following formula
Xn+1 = Xn + (−k1λXn)∆t+ (σ1Xn)∆Wn (8)
Yn+1 = Yn + (k1λXn − k2Yn)∆t+ (σ2Yn)∆Wn (9)
where ∆t = tn+1 − tn and ∆Wn = W (tn+1)−W (tn).
The increment of the Wiener process, ∆Wn is normal distributed with mean zero and variance,
∆t.
3.1. Maximum Likelihood Estimator
A non–parametric simulated maximum likelihood approach is applied to estimate the unknown
parameters of stochastic model. The transition density of yi starting from yi−1 and evolving to
yi is p(ti, yi|ti−1, yi−1, θ), where θ is the parameters to be estimated. The maximum likelihood
estimator for θ is obtained by maximizing the likelihood function of
L(θ) =
N∏
i=1
p(ti, yi|ti−1, yi−1; θ) (10)
The Monte Carlo simulation is used to derive L(θ) which is proposed by [14]. The algorithm is
presented below.
(i) Divide the time interval [ti−1, ti] into N subintervals with a step size of h =
(ti−1−ti)
N . The
stochastic model is integrated on this discretization by using Euler-Maruyama method.
This integration is repeated R times for R = 100 to generate R approximations of the
cancer treated X at ti starting with yi−1 at ti−1. The approximate values of cancer treated
is denoted as X1ti . . . X
R
ti , where X
r
ti is the integrated value of stochastic model in the r
th–
simulation for r = 1, . . . , R.
(ii) Then, a non–parametric kernel density is constructed from the simulated values of
X1ti . . . X
R
ti are used to construct a non–parametric kernel density estimate of the transition
density (10)
pR(ti, yi|ti−1, yi−1; θ) = 1
Rhi
R∑
r=1
K
(yi −Arti
hi
)
(11)
where hi is the kernel bandwidth at time ti and K(·) is a suitable symmetric, non–negative
kernel function enclosing unit mass.
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(iii) The previous procedure is repeated for each yi and the p
R(ti, yi|ti−1, yi−1; θ) thus obtained
used to construct LR(θ) =
∏N
i=1 p
R(ti, yi|ti−1, yi−1; θ).
(iv) LR(θ) is maximized to obtain the approximated MLE θR of θ.
Hurn et al. [14] is proposed a suitable choice of K(·) which is given by the normal kernel
K(u) =
1√
(2pi)
exp(
−u2
2
) (12)
with bandwith given by
hi =
4
3
1
5
siR
−1
5 , i = 1, . . . , N (13)
4. Material and Methods
4.1. Cell Line
Human breast cancer (MCF7) was kindly provided by Dr. Solachuddin Jauhari Arief Ichwan
From Kuliyyah of Dentistry, International Islamic University Malaysia (IIUM) Kuantan, Pahang.
The cell was cultured in DMEM (Gibco, California, USA) medium and maintained in a
humidified incubator with 5% CO2 and 95% air at 37
◦C.
4.2. Preparation of CS Solution
Blue-spotted stingray were used for extraction of CS. For extraction process, the powder form
of CS crudes were used for the experiment. CS crude products were courtesy from Dr Nina
Suhaity from University Malaysia Pahang.
4.3. Anti-Proliferation Assay
Cellular proliferation was determined by the ability of cells to convert soluble MTT (Sigma
Aldrich, St. Louis, Missouri, USA) to an insoluble coloured formazan precipitate. Exponentially
growing cells were plated onto 96-well plates following 24 hours at an initial density of
2 × 104/well, treated with defined concentrations of CS (12.5, 25, 50 and 100µg). Plates were
centrifuged at 1000 rpm to collect floating cells using a microplate swing rotor centrifuge. Then
carefully remove the media from the wells without disturbing the cell pellet. The cells were
incubated in 30 µl MTT (Sigma-Aldrich, USA) at concentration of 5 mg/ml in phosphate
buffer saline (PBS) for 2 hrs. The intercellular formazan complex was dissolved in DMSO. The
absorbance was measured at 570 nm by a microplate reader.
5. Result and Discussion
In this section, the simulated results is presented to understand the effects of therapies on growth
rate of cancer cell.
5.1. Analysis of Stochastic Model
For this purpose, the likelihood function LR(θ) for R = 100 are maximized to generate the
estimated values of θ = {k1, k2, σ1, σ2}. The construction of LR(θ) requires the generating
of Wiener increments ∆W (t) = W (tn) − W (tn−1). The increments are simulated by using
Box–Muller method and those values are kept fixed for a given optimization procedure. The
experimental data is generated at equally spaced intervals of time hn = tn−tn−1 = TN . Numerical
method is performed to simulate the trajectories in the interval time [t0, T ] with initial condition
of cell absorbance, X(t0) = 0.3123. Numerical optimization algorithm was implemented using
Matlab program and the estimated parameter values of θ = {k1, k2, σ1, σ2} for R = 100 are
listed in Table 5.1.
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Table 1. Maximum Likelihood Estimates of Stochastic Model Parameter
Mathematical Model k1 k2 σ1 σ2
Stochastic Model -0.54 0.41 0.05 0.04
Figure 2 shows the simulated results of stochastic models (6) and(7) with experimental data.
Based on Figure 2, the numerical result obtained via stochastic model is consistent with the
experimental data.
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Figure 2. Simulation Results of Stochastic Model with the Experimental Data of Cancerous
Growth with Treatment
Figure 3 is illustrates the result of Equation (7) over 100 trajectories. To confirm whether
apoptotic in these cells were mediated by caspase-3, the upregulated transcript levels of these
caspase in MCF-7 were simulated. It is shown that CS effects on caspase-3 activation are at the
trancriptional level.
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Figure 3. Caspase-3 activity assay
6. Conclusion
It is clear that for reducing cancerous growth, drug targeted therapy should be started as soon
as the cancer cell is detected and should be scheduled frequently. This finding provides useful
knowledge on the understanding of the interaction of CS with the cancer cell.
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